Literature DB >> 16382213

Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia.

Krzysztof Jamroziak1, Ewa Balcerczak, Barbara Cebula, Monika Kowalczyk, Mariusz Panczyk, Agnieszka Janus, Piotr Smolewski, Marek Mirowski, Tadeusz Robak.   

Abstract

P-glycoprotein (P-gp), a membrane transporter encoded by MDR1 gene, influences pharmacokinetics of anti-cancer drugs and contributes to multi-drug resistance phenotype in adult acute lymphoblastic leukemia (ALL). In this study, we explored prognostic and functional role of single nucleotide polymorphism C3435T in MDR1 gene in 44 adult Caucasian patients with ALL. We found that the outcome of chemotherapy as well as MDR1 gene expression, P-gp expression and P-gp activity in isolated ALL blast cells were comparable among the patients carrying different MDR1 genotypes. Our results suggest that C3435T polymorphism in MDR1 gene is not a major prognosticator in adult ALL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16382213

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.

Authors:  Francesco Ceppi; Chloé Langlois-Pelletier; Vincent Gagné; Julie Rousseau; Claire Ciolino; Samanta De Lorenzo; Kojok M Kevin; Diana Cijov; Stephen E Sallan; Lewis B Silverman; Donna Neuberg; Jeffery L Kutok; Daniel Sinnett; Caroline Laverdière; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2014-06       Impact factor: 2.533

2.  Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia.

Authors:  Xiaowen Zhai; Hongsheng Wang; Xiaohua Zhu; Hui Miao; Xiaowen Qian; Jun Li; Yijin Gao; Fengjuan Lu; Yue Wu
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

Review 3.  Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.

Authors:  Vid Mlakar; Patricia Huezo-Diaz Curtis; Chakradhara Rao Satyanarayana Uppugunduri; Maja Krajinovic; Marc Ansari
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

Review 4.  ABCB1 genetic variants in leukemias: current insights into treatment outcomes.

Authors:  Ravindran Ankathil
Journal:  Pharmgenomics Pers Med       Date:  2017-05-12

Review 5.  Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.

Authors:  Qing-Yan Yang; Ya-Hui Hu; Hong-Li Guo; Ying Xia; Yong Zhang; Wei-Rong Fang; Yun-Man Li; Jing Xu; Feng Chen; Yong-Ren Wang; Teng-Fei Wang
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.